Experiments for taxon Chrysanthemum lavandulaefolium (ASTERACEAE)

Experiments (33 results)

Filters
Worktypes (12)
17
13
8
6
5
5
5
5
5
3
2
1
No match
Pharmacology (11)
6
3
1
1
1
1
1
1
1
1
16
No match
Compounds (22)
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
17
No match
Organisms (9)
12
7
6
3
1
1
1
1
1
No match
33 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
10776
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIINFLAMMATORY ACTIVITY
Chrysanthemum lavandulaefolium (ASTERACEAE)
953899
PHARMACOLOGY OF EXTRACT - IN VITRO
ENDORPHIN BINDING INHIBITION
Chrysanthemum lavandulaefolium (ASTERACEAE)
112425
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum lavandulaefolium (ASTERACEAE)
TANAPARTHIN-ALPHA-PEROXIDE
792677
PHYTOCHEMICAL SCREENING FOR
Chrysanthemum lavandulaefolium (ASTERACEAE)
O
1199047
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum lavandulaefolium (ASTERACEAE)
953901
PHARMACOLOGY OF EXTRACT - IN VITRO
ANGIOTENSIN-II INHIBITION
Chrysanthemum lavandulaefolium (ASTERACEAE)
1199048
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum lavandulaefolium (ASTERACEAE)
953900
PHARMACOLOGY OF EXTRACT - IN VITRO
ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)
Chrysanthemum lavandulaefolium (ASTERACEAE)
112427
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum lavandulaefolium (ASTERACEAE)
TANAPARTHOLIDE A,SECO:
1211177
QUANTITATIVE DATAIDENTIFICATION OF
Chrysanthemum lavandulaefolium (ASTERACEAE)
FLUORIDE
1199046
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum lavandulaefolium (ASTERACEAE)
953902
PHARMACOLOGY OF EXTRACT - IN VITRO
CHOLECYSTOKININ RECEPTOR BINDING EFFECT
Chrysanthemum lavandulaefolium (ASTERACEAE)
112424
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum lavandulaefolium (ASTERACEAE)
CUMAMBRIN A
953898
PHARMACOLOGY OF EXTRACT - IN VITRO
DOPAMINE RECEPTOR BLOCKING EFFECT
Chrysanthemum lavandulaefolium (ASTERACEAE)
112430
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum lavandulaefolium (ASTERACEAE)
HANDELIN
1158147
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Chrysanthemum lavandulaefolium (ASTERACEAE)
1199049
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum lavandulaefolium (ASTERACEAE)
112421
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Chrysanthemum lavandulaefolium (ASTERACEAE)
SPIRO-[4-5]-DECANE,1-6-DIOXA: 3-4-DIACETOXY-2-(HEXA-2-4-DIYNYLIDEN): (3S-4S-5R)-TRANS: (-):
953903
PHARMACOLOGY OF EXTRACT - IN VITRO
HGPRT INHIBITION
Chrysanthemum lavandulaefolium (ASTERACEAE)
1158146
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Chrysanthemum lavandulaefolium (ASTERACEAE)
953897
PHARMACOLOGY OF EXTRACT - IN VITRO
BENZODIAZEPINE BINDING INHIBITION
Chrysanthemum lavandulaefolium (ASTERACEAE)
1199045
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum lavandulaefolium (ASTERACEAE)
112423
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Chrysanthemum lavandulaefolium (ASTERACEAE)
GERMACRA-4-CIS-10(14)-DIEN-12-6-OLIDE,1-BETA-HYDROPEROXY-3-BETA-HYDROXY: (6-BETA-7-ALPHA-11-ALPHA-H):
1199050
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Chrysanthemum lavandulaefolium (ASTERACEAE)
112429
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum lavandulaefolium (ASTERACEAE)
LEUCODIN,DEHYDRO:
112420
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Chrysanthemum lavandulaefolium (ASTERACEAE)
SPIRO-[4-5]-DECANE,1-6-DIOXA: 4-HYDROXY-3-ISO-VALEROYL-OXY-2-(HEXA-2-4-DIYNYLIDEN): (3S-4S-5R)-TRANS: (+):
1112091
ISOLATION AND IDENTIFICATION OF
Chrysanthemum lavandulaefolium (ASTERACEAE)
QUERCETIN GLYCOSIDEACACIINCYNAROSIDE
112419
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Chrysanthemum lavandulaefolium (ASTERACEAE)
SPIRO-[4-5]-DECANE,1-6-DIOXA: 8-ACETOXY-4-HYDROXY-3-ISO-VALEROYL-OXY-2-(HEXA-2-4-DIYNYLIDEN): (3S-4S-5R-8S)-TRANS: (+):
1158145
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Chrysanthemum lavandulaefolium (ASTERACEAE)
850300
PHYTOCHEMICAL SCREENING FOR
Chrysanthemum lavandulaefolium (ASTERACEAE)
OOOO
112422
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Chrysanthemum lavandulaefolium (ASTERACEAE)
GERMACRA-4-CIS-10(14)-DIEN-12-6-OLIDE,1-BETA-3-BETA-DIHYDROXY: (6-BETA-7-ALPHA-11-ALPHA-H):
112428
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum lavandulaefolium (ASTERACEAE)
KAUNIOLIDE
112426
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chrysanthemum lavandulaefolium (ASTERACEAE)
CANIN